BioCryst Pharmaceuticals

Youtube Subscribe

Open: 7.4 Close: 7.52 Change: 0.12

The stock market through the eyes of an AI: BioCryst Pharmaceuticals.

The game is changing. There is a new strategy to evaluate BioCryst Pharmaceuticals fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about BioCryst Pharmaceuticals are: Pharmaceuticals, company, stock, biotech, Inc, slip, Tuesday, …

Concept Map

Semantic Network

Stock Summary

BioCryst Pharmaceuticals, Inc. discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza.

Today's Summary

Neo Ivy Capital Management acquired a new stake in the company valued at about $188,000. Silverarc Capital Management LLC grew its position in BioCrySt Pharmaceuticals by nearly 46%.

Today's News

Biocryst Pharmaceuticals Inc. (bcrx) stock price today, news, quotes, faqs and fundamentals. Biocrysts Inc. stock is slipping on Tuesday after the biotech company announced new funding to pay down debts. Investors have taken notice of BioCryst Pharmaceuticals in recent years. Neo Ivy Capital Management acquired a new stake in the company valued at about $188,000. Silverarc Capital Management LLC grew its position in BioCrySt Pharmaceuticals by nearly 46%. BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced funding funding. The biotech company now is now is biocryst pharmaceutical incinel (NASdaq: BCRX) Now is the time to buy down debts to pay down.

Stock Profile

"BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina."

Keywords

How much time have you spent trying to decide whether investing in BioCryst Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about BioCryst Pharmaceuticals are: Pharmaceuticals, company, stock, biotech, Inc, slip, Tuesday, and the most common words in the summary are: pharmaceutical, therapeutic, biocryst, pharma, stock, inc, bioscience, . One of the sentences in the summary was: Neo Ivy Capital Management acquired a new stake in the company valued at about $188,000. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pharmaceutical #therapeutic #biocryst #pharma #stock #inc #bioscience.

Read more →

Youtube Subscribe

---